IL17A and systemic sclerosis: To further explore the IL-17 downstream signaling pathway in SSc, Ahmed et al. [130] have demonstrated that PD-1, SHP2, STAT3, Ras/Erk, mTOR and complement components are all involved in this particular signaling pathway.